STEPHEN PROHASKA: Open Payments
NPI 1356895197 · MORGANTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,783 in 126 payments from 22 companies in 2025. Trend: 2023 $176 · 2024 $2,412 · 2025 $4,783
Food & beverage: $3,328Consulting: $1,266Travel & lodging: $112Education: $77
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 17 | $2,094 |
| AstraZeneca Pharmaceuticals LP | 20 | $830 |
| GlaxoSmithKline, LLC. | 24 | $411 |
| Regeneron Healthcare Solutions, Inc. | 16 | $255 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $190 |
| Insmed, Inc. | 6 | $116 |
| Actelion Pharmaceuticals US, Inc. | 4 | $94 |
| United Therapeutics Corporation | 3 | $89 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $74 |
| Grifols USA, LLC | 4 | $65 |
Products named: DUPIXENT, AIRSUPRA, TRELEGY ELLIPTA, TEZSPIRE, NUCALA, BREZTRI, Arikayce, TYVASO.
Industry payments across NC — which companies pay providers there.
